Prognostic significance of systemic immune inflammatory index in NSCLC: a meta-analysis.
Lung Cancer Manag
; 13(1): LMT67, 2024.
Article
in En
| MEDLINE
| ID: mdl-38812771
ABSTRACT
Aim:
The aim of this meta-analysis was to investigate the relationship between the baseline systemic immune inflammatory index (SII) and prognosis in patients with NSCLC. Materials &methods:
The relation between pretreatment SII and overall survival, disease-free survival, cancer-specific survival, progression-free survival and recurrence-free survival in NSCLC patients was analyzed combined with hazard ratio and 95% CI.Results:
The results showed that high SII was significantly correlated with overall survival and progression-free survival of NSCLC patients, but not with disease-free survival, cancer-specific survival and recurrence-free survival.Conclusion:
The study suggests that a higher SII has association with worse prognosis in NSCLC patients. PROSPERO registration number CRD42022336270.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Lung Cancer Manag
Year:
2024
Document type:
Article
Affiliation country:
China